Feeds:
Posts
Comments

Posts Tagged ‘Takeda Pharmaceutical Company’

Keynote Address: Applying the Lessons of Philanthropy Tadataka “Tachi” Yamada, Chief Medical and Scientific Officer, Takeda Pharmaceuticals

Posted in Interviews with Scientific Leaders, Pharmaceutical Analytics, Pharmaceutical Industry Competitive Intelligence, tagged , , , , , on August 1, 2013| Leave a Comment »

Keynote Address Speaker and Panel Updates Announced

Reporter: Aviva Lev-Ari, PhD, RN

Article ID #72: Keynote Address: Applying the Lessons of Philanthropy Tadataka “Tachi” Yamada, Chief Medical and Scientific Officer, Takeda Pharmaceuticals. Published on 8/1/2013

WordCloud Image Produced by Adam Tubman

Scientific innovation is at the core of Big Pharma‘s business model, but continuous transformation critical to R&D momentum has been an ongoing, multi-year challenge. Big Pharma has struggled to manage costs while delivering on productivity. Unmet medical need remains a compelling scientific and business opportunity, as is development of truly differentiated medicines and orphan drugs.

 

R&D: Balancing Austerity and Innovation at the 23rd Annual PSA: The Pharmaceutical Strategy Conference, being held September 23-25, 2013 at the Millennium Broadway Hotel in New York City. Successful R&D leaders discuss their strategies for maintaining excellence and adaptability in the face of internal and external hurdles.

 

Matthias Evers, PhD (Moderator), Partner, McKinsey & Company 

George Yancopoulos, MD, PhD, President & CSO, Regeneron Pharmaceuticals

Rupert Vessey, SVP, R&D Strategy, Merck & Co., Inc.

JC Gutierrez-Ramos, SVP & Head of Biotherapeutics R&D, Pfizer

 

Keynote Address: Applying the Lessons of Philanthropy

Tadataka “Tachi” Yamada

Chief Medical and Scientific Officer

Takeda Pharmaceuticals

Read Full Post »